| Literature DB >> 22863368 |
Iftikhar Alam1, Anis Larbi, Graham Pawelec.
Abstract
Immune status is influenced by malnutrition, but how this factor interacts in developing countries and whether these differences are similar to those determined in industrialized countries, is unclear. To establish whether malnutrition-associated immune profiles in a developing country are similar to those in industrialized countries we analyzed peripheral blood immune cell phenotypes by polychromatic flow cytometry in 50 young and 50 elderly subjects. Data on anthropometrics and diet were collected through interviews. Plasma samples were analyzed for common clinical chemistry variables. Subjects in 4 BMI categories differed in their immune parameters demonstrating influence of nutritional status on immunity. This was greater within the young group and affected the CD4 subset more profoundly than the CD8 subset. No nutrition-associated differences were seen in B or NK cells. CD8+ cells as a percentage of CD3+ T cells were positively associated with plasma CRP levels but not other factors. We conclude that there are differences in the immune signatures of obese, overweight and underweight versus normal-weight young and elderly, which seem broadly similar to the more extensively-documented state reported in industrialized countries, despite the marked societal, nutritional and many other differences.Entities:
Year: 2012 PMID: 22863368 PMCID: PMC3488561 DOI: 10.1186/1742-4933-9-16
Source DB: PubMed Journal: Immun Ageing ISSN: 1742-4933 Impact factor: 6.400
General characteristics and nutrient intake of the subjects
| Age (years) | 24.2 (3.43) | 18.0–29.2 | 67.3 (8.77) | 50.1–85.5 | - |
| Weight (Kg) | 67.6 (14.02) | 45.3–92.4 | 68.7 (14.57) | 46.0–97.0 | 0.7329 |
| BMI (Kg/m2) | 25.0 (5.37) | 16.3–33.4 | 24.2 (5.47) | 15.4–33.8 | 0.5056 |
| WC | 82.1 (11.20) | 64.1–102.2 | 86.7 (12.39) | 62.1–113.2 | 0.0735 |
| WHR | 1.0 (0.11) | 0.70–1.17 | 0.9 (0.12) | 0.67–1.21 | 0.3676 |
| % BF | 17.7 (8.48) | 5.5–33.1 | 21.3 (7.99) | 9.0–32.6 | |
| Energy intake (Kcal) | 2344 (498.8) | 1262–3280 | 1778 (479.9) | 659–2487 | |
| Protein intake (g) | 48.8 (11.39) | 29.5–77.2 | 37.6 (12.19) | 14.6–68.6 | |
Mean (STD); p significant at á = 0.05.
CD4+ T cells and subsets in the 4 BMI categories of young subjects
| | |||||||
|---|---|---|---|---|---|---|---|
| CD4+ | 37.2 (6.71) | 24.3 (11.51) | 24.4 (11.60) | 26.8 (10.11) | 0.316 | 0.180 | |
| CD28+CD27+ | 54.3 (11.12) | 45.3 (14.19) | 45.1 (13.72) | 54.1 (15.81) | 0.2339 | 0.2213 | 0.2121 |
| CD28-CD27- | 12.3 (6.11) | 14.1 (10.61) | 14.7 (8.21) | 15.0 (7.43) | 0.9090 | 0.8150 | 0.7434 |
| CD45RO+CD27- | 21.2 (15.21) | 17.9 (9.21) | 16.1 (12.45) | 22.5 (14.27) | 0.8616 | 0.6492 | 0.9892 |
| CD45RO-CD27+ | 27.6 (16.12) | 30.9 (15.9) | 31.8 (15.31) | 30.3 (15.11) | 0.9159 | 0.8439 | 0.4312 |
| CD45RA+CD27+ | 33.6 (14.21) | 27.1 (8.81) | 19.6 (16.61) | 21.8 (19.71) | 0.5412 | 0.1139 | |
| CD45RA-CD27- | 14.1 (9.31) | 36.3 (10.71) | 42.1 (24.40) | 54.7 (35.62) | 0.3971 | ||
| CD45RO+CD28- | 8.8 (4.71) | 9.5 (7.32) | 6.2 (3.11) | 12.6 (4.72) | 0.9784 | 0.4521 | 0.1656 |
| CD45RO-CD28+ | 44.4 (14.81) | 31.2 (14.12) | 38.1 (17.51) | 30.9 (8.11) | 0.5733 | 0.5449 | 0.0511 |
| CD45RA+CD28+ | 33.8 (17.81) | 27.1 (20.62) | 17.5 (25.01) | 31.3 (14.21) | 0.7261 | 0.1053 | 0.1797 |
| CD45RA-CD28- | 16.7 (12.71) | 19.2 (20.21) | 23.4 (21.60) | 23.4 (14.32) | 0.9682 | 0.6445 | 0.6512 |
| TRegs | 3.9 (4.53) | 5.9 (5.72) | 4.8 (3.90) | 3.2 (4.31) | 0.5819 | 0.9172 | 0.9713 |
| CD28+CD27+KLRG1-CD57- | 37.1 (18.10) | 34.6 (16.61) | 30.1 (15.61) | 22.4 (20.31) | 0.9713 | 0.6355 | 0.1065 |
| CD28-CD27-KLRG1+CD57+ | 0.6 (0.90) | 0.6 (1.32) | 1.0 (1.51) | 2.3 (1.10) | 0.5436 | 0.8415 | |
Significant Dunnett’s test (p < 0.05) comparing CD4+ T subsets with the reference group. The reference group defined as having BMI, 18.5–24.9.OB, Obese; OW, Overweight; NW, Normal Weight; UW, Underweight. The values are means (SD).
CD8+ T cells and subsets in the 4 BMI categories of young subjects
| | |||||||
|---|---|---|---|---|---|---|---|
| CD8+ | 21.2 (2.76) | 17.4 (7.04) | 21.5 (4.88) | 19.1 (5.06) | 0.1549 | 0.5221 | 0.5324 |
| CD28+CD27+ | 37.4 (13.1) | 32.0 (8.08) | 33.4 (8.86) | 32.2 (8.18) | 0.3832 | 0.4239 | |
| CD28-CD27- | 29.0 (5.25) | 27.0 (8.03) | 28.6 (8.87) | 25.6 (4.26) | 0.7898 | 0.5432 | 0.4436 |
| CD45RO+CD27- | 6.4 (4.48) | 8.8 (6.91) | 5.7 (5.32) | 7.7 (4.03) | 0.5117 | 0.7566 | 0.8489 |
| CD45RO-CD27+ | 47.9 (7.74) | 43.2 (10.23) | 45.0 (13.11) | 32.6 (7.86) | 0.4886 | 0.8057 | |
| CD45RA+CD27+ | 32.8 (12.31) | 29.8 (11.89) | 32.3 (9.0) | 28.7 (13.77) | 0.8651 | 0.8774 | 0.7262 |
| CD45RA-CD27- | 10.4 (9.18) | 15.5 (9.40) | 12.7 (9.36) | 15.3 (10.98) | 0.4219 | 0.8945 | 0.4625 |
| CD45RO+CD28- | 11.4 (6.80) | 14.1 (5.57) | 17.3 (5.46) | 12.5 (4.90) | 0.5072 | 0.9321 | |
| CD45RO-CD28+ | 44.1 (13.06) | 43.0 (16.10) | 35.7 (10.53) | 38.7 (11.45) | 0.6588 | 0.2479 | 0.5923 |
| CD45RA+CD28+ | 41.9 (14.50) | 43.5 (17.43) | 46.2 (17.45) | 45.4 (15.10) | 0.6466 | 0.8344 | 0.9074 |
| CD45RA-CD28- | 20.1 (4.80) | 17.1 (5.54) | 20.5 (8.17) | 17.1 (9.24) | 0.5764 | 0.6455 | 0.5887 |
| CD28+CD27+KLRG1-CD57- | 24.3 (22.76) | 20.9 (15.45) | 22.0 (19.53) | 12.8 (12.42) | 0.3883 | 0.4239 | |
| CD28-CD27-KLRG1+CD57+ | 1.0 (1.45) | 1.0 (1.71) | 2.4 (1.32) | 3.4 (1.41) | 0.7898 | 0.5468 | 0.0487 |
Significant Dunnett’s test (p < 0.05) comparing CD8+ T subsets with the reference group. The reference group defined as having BMI, 18.5–24.9. OB, Obese; OW, Overweight; NW, Normal Weight; UW, Underweight. The values are means (SD).
CD4+ T cells and subsets in the 4 BMI categories of elderly subjects
| | |||||||
|---|---|---|---|---|---|---|---|
| CD4+ | 26.9 (12.21) | 23.8 (9.67) | 26.2 (9.91) | 22.5 (7.35) | 0.7925 | 0.5421 | 0.6352 |
| CD28+CD27+ | 17.9 (10.04) | 13.0 (9.87) | 16.6 (10.03) | 48.1 (14.3) | 0.4205 | 0.9944 | 0.4745 |
| CD28-CD27- | 43.2 (12.73) | 45.3 (16.01) | 47.4 (9.37) | 39.3 (12.45) | 0.9611 | 0.7724 | 0.6809 |
| CD45RO+CD27- | 39.3 (10.46) | 31.6 (12.75) | 31.0 (17.88) | 22.5 (14.21) | 0.5734 | 0.2912 | 0.5154 |
| CD45RO-CD27+ | 13.3 (9.36) | 22.1 (13.02) | 20.5 (15.92) | 30.3 (15.19) | 0.1882 | 0.3334 | 0.9878 |
| CD45RA+CD27+ | 14.0 (10.41) | 26.3 (14.89) | 19.9 (10.98) | 15.7 (12.71) | 0.4581 | 0.988 | |
| CD45RA-CD27- | 56.2 (19.32) | 33.6 (21.56) | 45.6 (17.47) | 49.5 (26.31) | 0.4559 | 0.7671 | |
| CD45RO+CD28- | 29.7 (12.89) | 20.5 (9.97) | 21.3 (14.16) | 27.4 (17.8) | 0.2348 | 0.3035 | 0.7543 |
| CD45RO-CD28+ | 16.6 (13.32) | 33.3 (13.28) | 21.0 (13.58) | 21.4 (14-8) | 0.7072 | 0.7521 | |
| CD45RA+CD28+ | 16.0 (12.23) | 19.2 (10.49) | 13.3 (11.20) | 14.8 (12.8) | 0.8368 | 0.8951 | 0.3426 |
| CD45RA-CD28- | 47.2 (16.28) | 36.8 (16.17) | 40.9 (13.92) | 48.6 (14.31) | 0.2274 | 0.6194 | 0.5461 |
| Tregs | 9.4 (4.81) | 7.9 (4.24) | 9.0 (4.66) | 14.0 (7.67) | 0.8512 | 0.4776 | 0.0918 |
| CD28+CD27+KLRG1-CD57- | 8.5 (8.60) | 8.3 (6.73) | 7.9 (5.71) | 13.2 (10.36) | 0.5123 | 0.4521 | 0.3249 |
| CD28-CD27-KLRG1+CD57+ | 10.7 (4.60) | 10.4 (4.67) | 9.8 (3.57) | 13.0 (7-08) | 0.5412 | 0.3421 | 0.4512 |
Significant Dunnett’s test (p < 0.05) comparing CD4+ and subsets with the reference group. The reference group defined as having BMI, 18.5–24.9. OB, Obese; OW, Overweight; NW, Normal Weight; UW, Underweight. The values are means (SD).
CD8+ T cells and subsets in the 4 BMI categories of elderly subjects
| | |||||||
|---|---|---|---|---|---|---|---|
| CD8+ | 28.5 (4.8) | 26.9 (5.8) | 25.0 (7.31) | 22.5 (6.31) | 0.8523 | 0.3514 | 0.0443 |
| CD28+CD27+ | 31.4 (7.32) | 27.9 (11.42) | 34.6 (6.42) | 32.7 (6.68) | 0.6545 | 0.5134 | 0.4219 |
| CD28-CD27- | 12.1 (6.52) | 14.4 (6.63) | 11.9 (6.01) | 8.4 (4.42) | 0.5696 | 0.648 | 0.9613 |
| CD45RO+CD27- | 15.1 (11.21) | 9.7 (5.86) | 9.2 (5.21) | 12.1 (10.01) | 0.1541 | 0.7298 | 0.5421 |
| CD45RO-CD27+ | 36.9 (7.21) | 34.2 (8.31) | 38.9 (9.61) | 35.2 (13.61) | 0.3854 | 0.5975 | 0.8712 |
| CD45RA+CD27+ | 18.3 (7.31) | 16.0 (9.02) | 17.8 (11.31) | 14.7 (7.91) | 0.3043 | 0.4237 | 0.6577 |
| CD45RA-CD27- | 44.9 (9.31) | 46.8 (13.01) | 40.9 (12.61) | 48.9 (14.23) | 0.3175 | 0.8401 | 0.2411 |
| CD45RO+CD28- | 28.8 (10.01) | 35.2 (6.71) | 34.3 (14.91) | 30.3 (9.01) | 0.8421 | 0.5411 | 0.6240 |
| CD45RO-CD28+ | 22.1 (8.0) | 17.2 (7.71) | 19.9 (9.21) | 19.9 (8.31) | 0.4954 | 0.1544 | 0.7662 |
| CD45RA+CD28+ | 11.2 (8.61) | 12.5 (7.21) | 13.9 (9.91) | 10.9 (5.81) | 0.4954 | 0.1544 | 0.7662 |
| CD45RA-CD28- | 51.0 (13.91) | 59.5 (12.71) | 57.4 (19.21) | 54.8 (15.61) | 0.2732 | 0.2153 | 0.7001 |
| CD28+CD27+KLRG1-CD57- | 10.5 (9.51) | 9.4 (4.31) | 8.3 (5.21) | 7.9 (7.01) | 0.8250 | 0.1931 | 0.5442 |
| CD28-CD27-KLRG1+CD57+ | 9.0 (6.11) | 6.5 (2.11) | 5.3 (2.21) | 9.6 (8.31) | 0.6545 | 0.5134 | 0.2775 |
Significant Dunnett’s test (p < 0.05) comparing CD8+ and subsets with the reference group. The reference group defined as having BMI, 18.5–24.9. OB, Obese; OW, Overweight; NW, Normal Weight; UW, Underweight. The values are means (SD).
B cells and NK cells in the 4 BMI categories of young subjects
| | |||||||
|---|---|---|---|---|---|---|---|
| B cells | 2.9 (2.45) | 3.8 (2.44) | 3.0 (2.10) | 1.9 (1.80) | 0.6368 | 0.5421 | 0.5520 |
| IgD+CD27- | 39.5 (13.0) | 39.9 (11.27) | 30.2 (11.35) | 32.2 (16.20) | 0.8581 | 0.1896 | 0.3731 |
| IgD-CD27+ | 16.3 (14.80) | 18.3 (12.11) | 22.9 (7.11) | 16.8 (13.82) | 0.7645 | 0.3172 | 0.8066 |
| NK Cells | 1.0 (3.05) | 0.6 (0.71) | 0.5 (0.64) | 0.5 (1.36) | 0.331 | 0.8060 | 0.7704 |
Significant Dunnett’s test (p < 0.05) comparing B cells and NK cells with the reference group. The reference group defined as having BMI, 18.5–24.9. OB, Obese; OW, Overweight; NW, Normal Weight; UW, Underweight.The values are means (SD).
B cells and NK cells in the 4 BMI categories of elderly subjects
| | |||||||
|---|---|---|---|---|---|---|---|
| B cells | 3.8 (2.19) | 4.3 (2.24) | 4.0 (1.57) | 2.7 (1.81) | 0.8483 | 0.8128 | 0.3471 |
| IgD+CD27- | 14.5 (6.14) | 7.8 (6.68) | 5.4 (4.35) | 25.1 (8.12) | 0.4307 | 0.2002 | |
| IgD-CD27+ | 24.6 (16.33) | 29.9 (12.8) | 34.5 (11.21) | 12.4 (13.08) | 0.6357 | 0.1720 | |
| NK Cells | 2.0 (2.2) | 0.7 (1.16) | 1.0 (1.59) | 1.0 (1.70) | 0.3822 | 0.3614 | |
Significant Dunnett’s test (p < 0.05) comparing B cells and NK cells with the reference group. The reference group defined as having BMI, 18.5–24.9. OB, Obese; OW, Overweight; NW, Normal Weight; UW, Underweight. The values are means (SD).
Multiple comparisons between the low risk group and other groups for percent CD4+, CD8+ and B cells
| CD4+ | MR | −15.1 | 0.070 | MR | −7.84 | 0.172 | HF | −1.47 | 0.113 | |
| | | HR | −0.93 | 0.738 | HR | −0.64 | 0.078 | LF | 1.24 | |
| | CD8+ | MR | −4.11 | 0.346 | MR | −3.04 | 0.990 | HF | −1.11 | 0.195 |
| | | HR | 0.35 | HR | −4.57 | 0.632 | LF | −1.92 | 0.343 | |
| | B cells | MR | −1.0 | 0.944 | MR | −0.92 | 0.434 | HF | −1.45 | 0.943 |
| | | HR | 0.41 | HR | −1.04 | 0.969 | LF | −0.72 | 0.281 | |
| CD4+ | MR | −9.75 | 0.983 | MR | −5.78 | 0.912 | HF | −6.80 | 0.489 | |
| | | HR | −7.67 | 0.727 | HR | −6.46 | 0.844 | LF | −7.16 | 0.550 |
| | CD8+ | MR | −3.62 | 0.822 | MR | −6.41 | 0.125 | HF | −4.03 | 0.932 |
| | | HR | −6.39 | 0.919 | HR | −2.41 | 0.484 | LF | −2.56 | 0.242 |
| | B cells | MR | −2.18 | 0.793 | MR | −1.46 | 0.921 | HF | −1.02 | 0.707 |
| HR | −2.07 | 0.873 | HR | −2.23 | 0.421 | LF | −0.77 | 0.226 |
1The mean difference is significant against low risk (LR) subjects at á = 0.05 level; MR, moderate risk; HR, high risk. For % BF, the mean difference is significant against normal fat subjects at the 0.05 level; LF, low; HF, high fat; Cat, category; 1p-values were calculated using Dunnett’s test. Positive values of the mean difference show pairs of means that are significantly different.
Figure 1Correlations between percentages of CD8+ and CD4+ cells and BMI and body fat. Significant at p < 0.05.